The latest discovery in breast cancer treatment is a win for research that puts patients, not drugs,
The New England Journal of Medicine recently published a study that’s made waves in the medical community. The trial assessed the usefulness of chemotherapy for a specific, common variant of breast cancer, and found that thousands of women may not actually need to undergo the intensive, painful treatment as part of their cancer-fighting regimen. The finding will likely benefit patients and their families, and the healthcare systems that look after them.
It also marks another important victory for something called a “non-inferiority trial.” This less well-known type of research is arguably our most powerful weapon in the war against unnecessary or harmful pharmaceuticals—and it starts with putting people first.
To read the full article, click HERE